ResearcherShandong UniversityActive in the last 2 years

Chenglin Zhu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3486-1936; OpenAlex author ID A5006537050. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

Contrast-enhanced CT-Derived extracellular volume fraction predicts survival in postoperative pancreatic cancer patients. Co-author DOI 10.1016/j.ejrad.2025.112273 ↗
Overexpression of the SMYD3 Promotes Proliferation, Migration, and Invasion of Pancreatic Cancer. Co-author DOI 10.1007/s10620-019-05797-y ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Qiang Huang · 1 shared paper, 2020 · strength 0.24
- Paper Overexpression of the SMYD3 Promotes Proliferation, Migration, and Invasion of Pancreatic Cancer. DOI 10.1007/s10620-019-05797-y ↗
Wei Wei · 1 shared paper, 2025 · strength 0.24
- Paper Contrast-enhanced CT-Derived extracellular volume fraction predicts survival in postoperative pancreatic cancer patient… DOI 10.1016/j.ejrad.2025.112273 ↗
Shuai Ming · 1 shared paper, 2025 · strength 0.24
- Paper Contrast-enhanced CT-Derived extracellular volume fraction predicts survival in postoperative pancreatic cancer patient… DOI 10.1016/j.ejrad.2025.112273 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.